Omega-3 Plus Low-Dose Aspirin in Smokers With Stage III Periodontitis

Summary

This randomized double-blind placebo-controlled clinical trial aims to evaluate the clinical and biochemical effects of omega-3 fatty acids combined with low-dose aspirin as an adjunct to scaling and root planing (SRP) in smoker patients with Stage III periodontitis. The study compares test and control groups regarding periodontal clinical parameters and gingival crevicular fluid interleukin-1 beta (IL-1β) levels Or other inflammatory markers that will be determined later at baseline, 3 months, and 6 months following treatment

Timeline

Start

2025-01-15

Primary completion

2026-07-30

Completion

2026-10-30

Drugs

Indications